1. Home
  2. MIRA

as of 01-22-2026 12:14pm EST

$1.48
+$0.09
+6.12%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Founded: 2020 Country:
United States
United States
Employees: N/A City: MIAMI
Market Cap: 61.1M IPO Year: 2023
Target Price: N/A AVG Volume (30 days): 135.4K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.61 EPS Growth: N/A
52 Week Low/High: $0.73 - $2.45 Next Earning Date: 11-13-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered MIRA Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 19 hours ago

AI Recommendation

hold
Model Accuracy: 0.00%
0.00%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest MIRA Pharmaceuticals Inc. News

MIRA Breaking Stock News: Dive into MIRA Ticker-Specific Updates for Smart Investing

All MIRA News

Share on Social Networks: